WallStreetZenWallStreetZen

NASDAQ: MDAI
Spectral Ai Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MDAI

Based on 1 analyst offering 12 month price targets for Spectral Ai Inc

Min Forecast
$4.00+113.9%
Avg Forecast
$4.00+113.9%
Max Forecast
$4.00+113.9%

Should I buy or sell MDAI stock?

Based on 1 analyst offering ratings for Spectral Ai Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MDAI's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MDAI as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their MDAI stock forecasts and price targets.

MDAI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-27Find Out Why

1 of 1

Forecast return on equity

Is MDAI forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is MDAI forecast to generate an efficient return on assets?

Company
N/A
Industry
14.3%

MDAI earnings per share forecast

What is MDAI's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$0.56
Avg 2 year Forecast
-$0.62
Avg 3 year Forecast
-$0.60

MDAI revenue forecast

What is MDAI's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$19.2M+13.16%
Avg 2 year Forecast
$23.4M+38.14%
Avg 3 year Forecast
$25.8M+52.49%
MDAI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MDAI revenue growth forecast

How is MDAI forecast to perform vs Medical Devices companies and vs the US market?

Company
15.63%
Industry
8.54%
Market
14.04%
MDAI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MDAI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MDAI vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
MDAI$1.87$4.00+113.90%Strong Buy
XTNT$0.42$1.00+139.81%Strong Buy
COCH$0.80$2.50+214.07%Buy
LUNG$1.48$9.50+541.89%Strong Buy
ECOR$8.28$18.00+117.39%Buy
View Top Medical Device Stocks

Spectral Ai Stock Forecast FAQ

Is Spectral Ai Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MDAI) stock is to Strong Buy MDAI stock.

Out of 1 analyst, 1 (100%) are recommending MDAI as a Strong Buy, 0 (0%) are recommending MDAI as a Buy, 0 (0%) are recommending MDAI as a Hold, 0 (0%) are recommending MDAI as a Sell, and 0 (0%) are recommending MDAI as a Strong Sell.

If you're new to stock investing, here's how to buy Spectral Ai stock.

What is MDAI's earnings growth forecast for 2026-2028?

(NASDAQ: MDAI) Spectral Ai's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.7%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.64%.

Spectral Ai's earnings in 2026 is -$13,880,000.On average, 5 Wall Street analysts forecast MDAI's earnings for 2026 to be -$17,690,953, with the lowest MDAI earnings forecast at -$17,465,003, and the highest MDAI earnings forecast at -$17,710,048. On average, 5 Wall Street analysts forecast MDAI's earnings for 2027 to be -$19,800,883, with the lowest MDAI earnings forecast at -$29,316,255, and the highest MDAI earnings forecast at -$9,356,252.

In 2028, MDAI is forecast to generate -$19,151,674 in earnings, with the lowest earnings forecast at -$28,692,505 and the highest earnings forecast at -$8,687,948.

What is MDAI's revenue growth forecast for 2026-2028?

(NASDAQ: MDAI) Spectral Ai's forecast annual revenue growth rate of 15.63% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.54%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.04%.

Spectral Ai's revenue in 2026 is $16,934,000.On average, 5 Wall Street analysts forecast MDAI's revenue for 2026 to be $609,843,025, with the lowest MDAI revenue forecast at $582,442,573, and the highest MDAI revenue forecast at $631,546,982. On average, 5 Wall Street analysts forecast MDAI's revenue for 2027 to be $744,458,481, with the lowest MDAI revenue forecast at $140,343,774, and the highest MDAI revenue forecast at $1,382,306,612.

In 2028, MDAI is forecast to generate $821,758,941 in revenue, with the lowest revenue forecast at $261,975,045 and the highest revenue forecast at $1,411,170,967.

What is MDAI's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MDAI) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 14.3%.

What is MDAI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MDAI price target, the average MDAI price target is $4.00, with the highest MDAI stock price forecast at $4.00 and the lowest MDAI stock price forecast at $4.00.

The Wall Street analyst predicted that Spectral Ai's share price could reach $4.00 by May 27, 2027. The average Spectral Ai stock price prediction forecasts a potential upside of 113.9% from the current MDAI share price of $1.87.

What is MDAI's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MDAI) Spectral Ai's current Earnings Per Share (EPS) is -$0.50. On average, analysts forecast that MDAI's EPS will be -$0.56 for 2026, with the lowest EPS forecast at -$0.55, and the highest EPS forecast at -$0.56. On average, analysts forecast that MDAI's EPS will be -$0.62 for 2027, with the lowest EPS forecast at -$0.92, and the highest EPS forecast at -$0.29. In 2028, MDAI's EPS is forecast to hit -$0.60 (min: -$0.90, max: -$0.27).

What is MDAI's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MDAI) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.